Molnupiravir
Sold as Molnupiravir DRL, Lagevrio, Molnarz, Molumus
[(2R,3S,4R,5R)-3,4-Dihydroxy-5-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate
Drag to rotate. Structure from PubChem CID 145996610.
Background
Registration
- Applicants
- 4
- Registrations
- 4
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Dr Reddyæs Laboratories (Pty) LtdCertificate held by Dr. Reddy’s Laboratories (Pty) Ltd | Molnupiravir DRL | 200 mg | 561109 | S4 | PIPIL |
| Msd (Pty) Ltd | Lagevrio | 200 mg | 561225 | S4 | PIPIL |
| Aurogen South Africa (Pty) LtdCertificate held by Aurogen SA (Pty) Ltd | Molnarz | 200 mg | 570169 | S4 | PIPIL |
| Bliss Pharmaceuticals (Pty) Ltd | Molumus | 200 mg | 570271 | S4 | PIPIL |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Molnupiravir 200 DRL EACH CAPSULE CONTAINS MOLNUPIRAVIR 200,0 mg | 200 mgCapsule | 56110956/20.2.8/1109Approved 25 July 2023 | Registered | S4 | PIPIL |
| Lagevrio Molnupiravir | 200 mgCapsules | 56122556/20.2.8/1225Approved 6 December 2022 | Registered | S4 | PIPIL |
| Molnarz EACH CAPSULE CONTAINS MOLNUPIRAVIR 200,0 mg | 200 mgCapsule | 57016957/20.2.8/0169Approved 25 July 2023 | Registered | S4 | PIPIL |
| Molumus 200 EACH CAPSULE CONTAINS MOLNUPIRAVIR 200,0 mg | 200 mgCapsule | 57027157/20.2.8/0271Approved 18 July 2023 | Registered | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Molnupiravir
S4: Molnupiravir
Consolidated Schedules 06 July 2026, line 7165
Pharmacological class: Antiviral agents. (class 20.2.8)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Molnupiravir 200 DRL, Dr Reddyæs Laboratories (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.